Skip to main content
. Author manuscript; available in PMC: 2015 Feb 23.
Published in final edited form as: Clin Infect Dis. 2006 Apr 26;42(11):1570–1577. doi: 10.1086/503423

Table 2. Day 42 treatment failure rates following completion of artemether-lumefantrine (AL) therapy.

AL regimen
Rate 4 doses over 48 h 6 doses over 60 h 6 doses over 96 h P
Day 42 uncorrected rate of recurrent parasitemia, % (95% CI) 20 (15–24)a 13 (11–15)b 3.9 (0–9.6) .001

Day 42 rate of recrudescence, % (95% CI) 13.3 (9.6–17)c 3.2 (1.8–4.6)d 0 <.001

Day 42 rate of reinfection, % (95% CI) 7.7 (4.8–10.6)e 11.7 (9.6–13.7)f 3.9 (0–9.6) .07
a

48-h regimen vs. 60-h regimen, P = .005.

b

60-h regimen vs. 96-h regimen, P = .01.

c

48-h regimen vs. 60-h regimen, P< .001.

d

60-h regimen vs. 96-h regimen, P = .17.

e

48-h regimen vs. 60-h regimen, P = .14.

f

60-h regimen vs. 96-h regimen, P = .08.